Cargando...
Transferability of Economic Evaluations of Treatments for Advanced Melanoma
BACKGROUND: Differing methodological requirements and decision-making criteria are recognised as barriers to transferability of cost-effectiveness analysis (CEA) across jurisdictions. OBJECTIVE: We assessed the generic and specific transferability of published CEAs of systemic treatments for advance...
Guardado en:
| Publicado en: | Pharmacoeconomics |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7081651/ https://ncbi.nlm.nih.gov/pubmed/31761996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-019-00860-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|